glycopyrrolate has been researched along with phenyl acetate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kopelent, H; Lachmann, B; Nebiu, D; Noe, CR; Walter, M | 1 |
| Gallo, O; Mangia, PP; Pradelli, L; Ritrovato, D | 1 |
| D'Andrea, P; Hosoe, M; Matsuo, K; Nakamura, Y; Pethe, A; Sagara, H; Tanaka, Y; Tanase, AM | 1 |
1 trial(s) available for glycopyrrolate and phenyl acetate
| Article | Year |
|---|---|
Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week st
Topics: Acetates; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Asthma; Bronchodilator Agents; Drug Combinations; East Asian People; Glycopyrrolate; Humans; Mometasone Furoate; Treatment Outcome | 2023 |
2 other study(ies) available for glycopyrrolate and phenyl acetate
| Article | Year |
|---|---|
Determination of (R,R)-glycopyrronium bromide and its related impurities by ion-pair HPLC.
Topics: Acetates; Buffers; Chromatography, High Pressure Liquid; Drug Contamination; Glycopyrrolate; Hydrogen-Ion Concentration; Muscarinic Antagonists; Reproducibility of Results; Spectrophotometry, Ultraviolet; Temperature | 2007 |
Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Ag
Topics: Acetates; Adrenal Cortex Hormones; Adult; Asthma; Bronchodilator Agents; Cost-Benefit Analysis; Drug Combinations; Glycopyrrolate; Humans; Indans; Mometasone Furoate; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Treatment Outcome | 2021 |